Bright Minds Biosciences Inc. DRUG
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.73M | -7.62M | -5.43M | -2.97M | -3.79M |
| Total Depreciation and Amortization | 14.10K | 14.40K | 14.20K | 12.30K | 11.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.49M | -156.70K | 1.96M | 1.17M | 1.52M |
| Change in Net Operating Assets | -813.90K | 1.03M | -714.70K | 865.20K | -274.30K |
| Cash from Operations | -6.03M | -6.74M | -4.17M | -920.60K | -2.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.40K | -26.30K | -26.00K | -26.10K | -25.60K |
| Issuance of Common Stock | 109.60K | 243.29M | 13.95M | 36.21M | 8.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -14.80M | -536.10K | -2.87M | 0.00 |
| Cash from Financing | 60.10K | 166.55M | 9.61M | 24.19M | -12.20K |
| Foreign Exchange rate Adjustments | 4.62M | 1.04M | -1.03M | -384.10K | -557.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.35M | 160.84M | 4.40M | 22.89M | -3.10M |